PA8489901A1 - Derivados de monosacaridos como inhibidores de adhesion celular - Google Patents

Derivados de monosacaridos como inhibidores de adhesion celular

Info

Publication number
PA8489901A1
PA8489901A1 PA20008489901A PA8489901A PA8489901A1 PA 8489901 A1 PA8489901 A1 PA 8489901A1 PA 20008489901 A PA20008489901 A PA 20008489901A PA 8489901 A PA8489901 A PA 8489901A PA 8489901 A1 PA8489901 A1 PA 8489901A1
Authority
PA
Panama
Prior art keywords
cell adhesion
derivatives
compounds
adhesion inhibitors
isopropilideno
Prior art date
Application number
PA20008489901A
Other languages
English (en)
Spanish (es)
Inventor
Sudershan K Arora
Jang B Gupta
Nawal Kishore
Vishwas D Joshi
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of PA8489901A1 publication Critical patent/PA8489901A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Surgery (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PA20008489901A 1999-01-15 2000-01-14 Derivados de monosacaridos como inhibidores de adhesion celular PA8489901A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN86DE1999 IN190975B (OSRAM) 1999-01-15 1999-01-15
US09/276,368 US6590085B1 (en) 1999-01-15 1999-03-25 Derivatives of monosaccharides as cell adhesion inhibitors

Publications (1)

Publication Number Publication Date
PA8489901A1 true PA8489901A1 (es) 2000-09-29

Family

ID=11088155

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20008489901A PA8489901A1 (es) 1999-01-15 2000-01-14 Derivados de monosacaridos como inhibidores de adhesion celular

Country Status (30)

Country Link
US (5) US6590085B1 (OSRAM)
EP (1) EP1147119B1 (OSRAM)
JP (1) JP2002534530A (OSRAM)
CN (1) CN1167707C (OSRAM)
AR (1) AR022235A1 (OSRAM)
AT (1) ATE250074T1 (OSRAM)
AU (1) AU768511B2 (OSRAM)
BG (1) BG105745A (OSRAM)
BR (1) BR0007553A (OSRAM)
CA (1) CA2359986A1 (OSRAM)
CO (1) CO5180591A1 (OSRAM)
CR (1) CR6423A (OSRAM)
CZ (1) CZ20012540A3 (OSRAM)
DE (1) DE60005300T2 (OSRAM)
DK (1) DK1147119T3 (OSRAM)
ES (1) ES2206176T3 (OSRAM)
HR (1) HRP20010529B1 (OSRAM)
HU (1) HUP0105116A3 (OSRAM)
ID (1) ID30351A (OSRAM)
IN (1) IN190975B (OSRAM)
MA (1) MA25342A1 (OSRAM)
MX (1) MXPA01007187A (OSRAM)
MY (1) MY121135A (OSRAM)
NZ (2) NZ527483A (OSRAM)
PA (1) PA8489901A1 (OSRAM)
PT (1) PT1147119E (OSRAM)
SK (1) SK284241B6 (OSRAM)
TR (1) TR200102043T2 (OSRAM)
WO (1) WO2000042054A1 (OSRAM)
YU (1) YU50701A (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190975B (OSRAM) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd
CN1812983A (zh) 2003-05-30 2006-08-02 兰贝克赛实验室有限公司 取代的吡咯衍生物及其作为hmg－co抑制剂的用途
US20090221515A1 (en) * 2004-09-02 2009-09-03 Viswajanani Jitendra Sattigeri Monosaccharide derivatives
JP2008525421A (ja) * 2004-12-22 2008-07-17 ランバクシー ラボラトリーズ リミテッド モノサッカリド誘導体
EP1915160A2 (en) * 2005-07-22 2008-04-30 Ranbaxy Laboratories Limited Derivatives of monosaccharides for the treatment of copd and allergic rhinitis
SG166829A1 (en) * 2005-11-08 2010-12-29 Ranbaxy Lab Ltd Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
US20080114031A1 (en) * 2006-03-29 2008-05-15 Sattigeri Viswajanani J Monosaccharide derivatives
EP1864992A2 (en) * 2006-05-30 2007-12-12 Ranbaxy Laboratories, Ltd. Monosaccharide derivatives
EP1953170A1 (en) * 2006-10-03 2008-08-06 Ranbaxy Laboratories Limited Monosaccharide derivatives as anti-inflammatory agents
AU2008221506B2 (en) * 2007-09-20 2011-01-20 ResMed Pty Ltd Retractable Tube for CPAP

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2715121A (en) 1950-09-09 1955-08-09 American Home Prod Alkyl sugar derivatives and their preparation
US4056322A (en) 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
US4735934A (en) 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
US4996195A (en) 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5010058A (en) * 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
FR2652540B1 (fr) 1989-10-02 1995-06-02 Imaje Sa Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre.
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
US5258402A (en) 1992-06-11 1993-11-02 Mcneil-Ppc, Inc. Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
US5432163A (en) 1992-11-13 1995-07-11 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
US5637570A (en) * 1995-05-09 1997-06-10 Chemora Pharmochem Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
IN190975B (OSRAM) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
ID30351A (id) 2001-11-22
HUP0105116A3 (en) 2003-05-28
IN190975B (OSRAM) 2003-09-06
CN1167707C (zh) 2004-09-22
ES2206176T3 (es) 2004-05-16
BR0007553A (pt) 2001-12-18
CR6423A (OSRAM) 2004-03-09
HRP20010529A2 (en) 2002-08-31
WO2000042054A1 (en) 2000-07-20
EP1147119A1 (en) 2001-10-24
US7005422B2 (en) 2006-02-28
MY121135A (en) 2005-12-30
US20040018995A1 (en) 2004-01-29
HUP0105116A2 (hu) 2003-04-28
TR200102043T2 (tr) 2001-11-21
HRP20010529B1 (en) 2005-02-28
AU1886100A (en) 2000-08-01
US20040019191A1 (en) 2004-01-29
HK1041270A1 (en) 2002-07-05
NZ512852A (en) 2004-02-27
NZ527483A (en) 2005-02-25
BG105745A (en) 2002-05-31
YU50701A (sh) 2005-06-10
CA2359986A1 (en) 2000-07-20
US6590085B1 (en) 2003-07-08
MA25342A1 (fr) 2001-12-31
CN1343213A (zh) 2002-04-03
SK284241B6 (en) 2004-11-03
PT1147119E (pt) 2004-02-27
EP1147119B1 (en) 2003-09-17
US20040029820A1 (en) 2004-02-12
AU768511B2 (en) 2003-12-18
DK1147119T3 (da) 2004-01-19
SK10132001A3 (sk) 2002-01-07
US20040023900A1 (en) 2004-02-05
CZ20012540A3 (cs) 2002-02-13
US7037899B2 (en) 2006-05-02
CO5180591A1 (es) 2002-07-30
US7005516B2 (en) 2006-02-28
DE60005300T2 (de) 2004-07-15
DE60005300D1 (de) 2003-10-23
AR022235A1 (es) 2002-09-04
JP2002534530A (ja) 2002-10-15
ATE250074T1 (de) 2003-10-15
MXPA01007187A (es) 2002-04-24

Similar Documents

Publication Publication Date Title
MX2019007708A (es) Nuevos agentes anti-inflamatorios.
ES2183937T3 (es) Inhibidores de la adhesion celular.
EA199800119A1 (ru) Ингибиторы адгезии клеток
MX9702125A (es) Composiciones y metodos para tratar condiciones inflamatorias mediadas por mastocitos.
UY27437A1 (es) Compuestos químicos
BR9808998A (pt) Imidazóis substituìdos úteis no tratamento de doenças inflamatórias
BR0208667A (pt) Antagonistas da função de mcp-1 e métodos de uso dos mesmos
ECSP055856A (es) Derivados de 3-aminopirrolidina como moduladores de receptores de quimocina
BR0009869A (pt) Método para inibir a produção e/ou secreção de citoquina, e, composição farmacêutica
AR011168A1 (es) Compuestos derivados del acido hexanoico, composiciones que los contiene, y procedimiento de tratamiento
ES8802386A1 (es) Procedimiento para prepara (1,2,4)-triazolo (1,5-c)quinazolinas
MX2010007024A (es) Tioéteres c-21 como agonista del receptor de glucocorticoides.
ES8305681A1 (es) Procedimiento para la obtencion de fenileteres sustituidos.
AR022235A1 (es) Derivados de monosacaridos como inhibidores de la adhesion celular
AR004480A1 (es) Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen
CA2411671A1 (en) Inhibitors of alpha l beta 2 mediated cell adhesion
DE69406434D1 (de) Herstellung von kompositwerkstoffen auf kohlenstoffbasis als bauteile für zellen zur aluminiumherstellung
ES8703447A1 (es) Procedimiento para la preparacion de una (2-3-trans)-lactona
ES8607274A1 (es) Un procedimiento para la preparacion de nuevos 2,5-diaril-tetrahidrotiofenos y analogos de los mismos.
ES8500318A1 (es) Esteres de halofenilgliceridos
BR0110358A (pt) P-(sulfonil)-arila e -heteroarilas
ES8703428A1 (es) Procedimiento para la obtencion de compuestos de amida
WO2006016237A3 (en) Heterocyclic derivatives as anti-inflammatory agents
EP4743402A1 (en) SODIUM CARBONATE OR BICARBONATE ELECTRICITY PRODUCTION PLANT
DE60332931D1 (en) Hydroxamsäurederivate